"A sharp rise in the incidence of congenital syphilis between 2012 and 2014 parallels a national increase in primary and secondary syphilis among women during the same period, according to the Centers for Disease Control and Prevention (CDC). The "...
VANDAZOLE (metronidazole vaginal gel) is indicated in the treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, Corynebacterium vaginitis, or anaerobic vaginosis) in non-pregnant women.
DOSAGE AND ADMINISTRATION
The recommended dose is one applicator full of VANDAZOLE (metronidazole vaginal gel) , (approximately 5 grams of gel containing approximately 37.5 mg of metronidazole) administered intravaginally once a day for 5 days. For once a day dosing, VANDAZOLE should be administered at bedtime [see PATIENT INFORMATION].
Not for ophthalmic, dermal, or oral use.
Dosage Forms And Strengths
VANDAZOLE (metronidazole vaginal gel) is a vaginal gel 0.75% in a 70 g tube with 5 vaginal applicators (each applicator delivers approximately 5 g of gel containing 37.5 mg of metronidazole).
Storage And Handling
VANDAZOL E (metronidazo le vaginal gel, 0.75%) is supplied in a 70 gram tube and packaged with 5 vaginal applicators.
Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Avoid exposure to extreme heat or cold. Protect from freezing.
Manufactured For: UPSHER-SMITH LABORATORIES, INC. Minneapolis, MN 55447. Rev. 1/2011This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/4/2011
Additional Vandazole Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.